What the evidence says. Graded mixed: individual RCTs report benefit for surgical trismus, breast engorgement and sputum clearance, but trials are small, often old, open-label or industry-linked, the best meta-analysis found benefit only for trismus (not pain or swelling), and a 2013 systematic review judged the evidence insufficient to recommend it. (Mixed evidence: Conflicting results across studies; benefit uncertain.)
What is Serrapeptase?
Serrapeptase (Serratiopeptidase) is a joint and skin supplement used for reduce post-surgical swelling. NutriDex grades the human evidence as Mixed. Serrapeptase is a proteolytic enzyme originally isolated from silkworm-gut bacteria (Serratia) and sold as an enteric-coated supplement for inflammation, swelling and mucus. Small randomized trials show some real but narrow effects: after impacted third-molar surgery it improved jaw opening and swelling versus placebo, and a 2023 meta-analysis of six trials confirmed a benefit for trismus but not for pain or swelling. Older RCTs report less breast engorgement (about 86% vs 60% improved) and thinner, more easily cleared sputum in chronic airway disease. Head-to-head, dexamethasone outperformed it for swelling and pain, and a 2026 study found no antifibrotic benefit after liposuction. Most trials are small, short, open-label or company-linked, and oral bioavailability is uncertain because the enzyme is a large, acid-sensitive protein. A 2013 systematic review concluded the evidence is too weak to recommend it.
Purported Benefits
✓Reduce post-surgical swelling
✓Ease jaw stiffness (trismus)
✓Thin and clear mucus
✓Anti-inflammatory adjunct
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
Commonly 10–60 mg/day (≈20,000–120,000 SPU) as enteric-coated tablets, taken on an empty stomach in 2–3 divided doses.
Active Compounds
Serratiopeptidase (a serine metalloprotease from Serratia E15)
Safety & Cautions
⚠
Generally well tolerated short-term; common effects are nausea, GI upset, skin rash and cough. Because it breaks down fibrin, it may add to bleeding risk with anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel, DOACs) and should be stopped before surgery; avoid in active abscess, as it can degrade the fibrin barrier and spread infection. Rare but serious reports include eosinophilic pneumonitis, bullous skin reactions and hemorrhage; long-term safety data are lacking and it is not recommended in pregnancy or breastfeeding given limited evidence. Educational only — always check with your doctor or pharmacist before combining Serrapeptase with any medicine.
Serrapeptase drug interactions
Known or theoretical interactions between Serrapeptase and common medications — educational, not exhaustive. Always check with your doctor or pharmacist before combining Serrapeptase with any medicine.
Serrapeptase is most often taken for Reduce post-surgical swelling, Ease jaw stiffness (trismus), Thin and clear mucus, Anti-inflammatory adjunct. Proteolytic enzyme marketed for inflammation, swelling and pain.
Does Serrapeptase work — what does the evidence say?
Mixed evidence. Conflicting results across studies; benefit uncertain. Serrapeptase is a proteolytic enzyme originally isolated from silkworm-gut bacteria (Serratia) and sold as an enteric-coated supplement for inflammation, swelling and mucus. Small randomized trials show some real but narrow effects: after impacted third-molar surgery it improved jaw opening and swelling versus placebo, and a 2023 meta-analysis of six trials confirmed a benefit for trismus but not for pain or swelling. Older RCTs report less breast engorgement (about 86% vs 60% improved) and thinner, more easily cleared sputum in chronic airway disease. Head-to-head, dexamethasone outperformed it for swelling and pain, and a 2026 study found no antifibrotic benefit after liposuction. Most trials are small, short, open-label or company-linked, and oral bioavailability is uncertain because the enzyme is a large, acid-sensitive protein. A 2013 systematic review concluded the evidence is too weak to recommend it.
What is the typical dose of Serrapeptase?
Commonly 10–60 mg/day (≈20,000–120,000 SPU) as enteric-coated tablets, taken on an empty stomach in 2–3 divided doses.
Is Serrapeptase safe? Any cautions or side effects?
Generally well tolerated short-term; common effects are nausea, GI upset, skin rash and cough. Because it breaks down fibrin, it may add to bleeding risk with anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel, DOACs) and should be stopped before surgery; avoid in active abscess, as it can degrade the fibrin barrier and spread infection. Rare but serious reports include eosinophilic pneumonitis, bullous skin reactions and hemorrhage; long-term safety data are lacking and it is not recommended in pregnancy or breastfeeding given limited evidence.
How many studies support Serrapeptase?
NutriDex cites 10 sources for Serrapeptase, graded "Mixed".
Does Serrapeptase interact with any medications?
Yes — known or theoretical interactions include: Blood thinners (warfarin, DOACs) (caution), Antiplatelet drugs (aspirin, clopidogrel) (caution). This is educational and not exhaustive; always check with your doctor or pharmacist before combining Serrapeptase with any medicine.
Cite this page
APA
Peh, D. (2026). Serrapeptase (Serratiopeptidase): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 16 Sept 2026, from https://nutridex.info/s/serrapeptase
BibTeX
@misc{nutridex_serrapeptase,
author = {Peh, Daryl},
title = {Serrapeptase (Serratiopeptidase): Benefits, Dosage, Side Effects \& Evidence},
year = {2026},
howpublished = {NutriDex --- The Supplement Research Compendium},
url = {https://nutridex.info/s/serrapeptase},
note = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-09-16}
}
For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.